InsidersTradesSigma
Explore the full record of transactions filed by Call Matthew, Chief Operating Officer. Officer active across 2 companies, notably iTeos Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was disclosed on 30 July 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Matthew Call serves as Chief Operating Officer of iTeos Therapeutics, Inc. He oversees the company's daily operations and ensures the efficiency of internal processes. Matthew plays a key role in implementing the business strategy and optimizing resources to support iTeos' growth.